Management of type 1 gastric neuroendocrine tumors: an 11-year retrospective single-center study

Type 1 gastric neuroendocrine tumors (NETs) are relatively rare to the extent that some physicians have little experience in diagnosing and treating them. The purpose of this study was to increase the understanding of the disease by analyzing and summarizing the management and prognoses of patients with type 1 gastric NETs at our center. The data of 229 patients (59.4